• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植术后活检中关于移植物排斥与非排斥情况的趋势。

Trends in post-heart transplant biopsies for graft rejection versus nonrejection.

作者信息

Jamil Aayla K, Afzal Aasim, Nisar Tariq, Kluger Aaron Y, Felius Joost, Wencker Detlef, Hall Shelley A, Kale Parag

机构信息

Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, Texas.

Annette C. and Harold C. Simmons Transplant Institute, Baylor Scott & White Research Institute, Dallas, Texas.

出版信息

Proc (Bayl Univ Med Cent). 2021 Jan 26;34(3):345-348. doi: 10.1080/08998280.2021.1873032.

DOI:10.1080/08998280.2021.1873032
PMID:33953457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8059886/
Abstract

With alternatives such as gene profiling available for surveillance after orthotopic heart transplantation, we sought to evaluate the utilization of endomyocardial biopsies (EMBs) for hospitalized patients after heart transplantation. Surveillance EMBs in patients with and without complications were evaluated from the 2004 to 2014 National Inpatient Sample. Over the study period, there was no significant change in the number of EMB procedures performed ( = 0.44). Of 37,955 EMBs, 2283 (6%) were in the setting of graft complications, while 35,672 EMBs were not related to graft complications. EMBs in graft complications did not show a significant increase in length of stay over time ( = 0.06), but had a significant increase in cost over time ( = 0.001). However, those with graft complications had an average of a 5-day longer length of stay ( < 0.001) and costs that were $88,816 ( < 0.001) more expensive compared with those without graft complications. In conclusion, the vast majority of in-hospital EMBs were not related to heart transplantation complications. Nevertheless, EMB hospitalizations with graft complications showed significantly greater length of stay and cost. With the COVID-19 pandemic, it seems more effective to use minimal-contact health surveillance methods rather than invasive EMBs.

摘要

由于原位心脏移植后有基因谱分析等替代方法可用于监测,我们试图评估心脏移植后住院患者心内膜心肌活检(EMB)的使用情况。我们从2004年至2014年的全国住院患者样本中评估了有并发症和无并发症患者的监测性EMB。在研究期间,进行EMB操作的数量没有显著变化(=0.44)。在37955次EMB中,2283次(6%)是在移植物并发症的情况下进行的,而35672次EMB与移植物并发症无关。移植物并发症患者的EMB住院时间随时间没有显著增加(=0.06),但费用随时间有显著增加(=0.001)。然而,与无移植物并发症的患者相比,有移植物并发症的患者平均住院时间长5天(<0.001),费用高出88816美元(<0.001)。总之,绝大多数住院期间的EMB与心脏移植并发症无关。然而,有移植物并发症的EMB住院患者的住院时间和费用显著更高。在新冠疫情期间,使用最少接触的健康监测方法似乎比侵入性的EMB更有效。

相似文献

1
Trends in post-heart transplant biopsies for graft rejection versus nonrejection.心脏移植术后活检中关于移植物排斥与非排斥情况的趋势。
Proc (Bayl Univ Med Cent). 2021 Jan 26;34(3):345-348. doi: 10.1080/08998280.2021.1873032.
2
Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care System.澳大利亚医疗体系中心血管磁共振成像用于心脏移植术后排斥反应监测的成本效益分析
Heart Lung Circ. 2024 Aug;33(8):1173-1183. doi: 10.1016/j.hlc.2024.03.004. Epub 2024 Apr 11.
3
Incidence of Acute Rejection Compared With Endomyocardial Biopsy Complications for Heart Transplant Patients in the Contemporary Era.当代心脏移植患者急性排斥反应发生率与心内膜心肌活检并发症的比较
Transplantation. 2024 May 1;108(5):1220-1227. doi: 10.1097/TP.0000000000004882. Epub 2023 Dec 15.
4
Cost and Use Trends of Endomyocardial Biopsy in Heart Transplant Patients: A 4-Year Claims Data Analysis.心内膜心肌活检在心脏移植患者中的成本和使用趋势:一项为期 4 年的理赔数据分析。
Transplant Proc. 2023 Nov;55(9):2186-2190. doi: 10.1016/j.transproceed.2023.08.016. Epub 2023 Oct 6.
5
Benefit versus Risk of Endomyocardial Biopsy for Heart Transplant Patients in the Contemporary Era.当代心脏移植患者心内膜心肌活检的获益与风险
medRxiv. 2023 Jul 28:2023.05.19.23290196. doi: 10.1101/2023.05.19.23290196.
6
Ten-Year Experience with Endomyocardial Biopsy after Orthotopic Heart Transplantation: Comparison between Trans-Jugular and Trans-Femoral Approach.原位心脏移植后心内膜心肌活检的十年经验:经颈静脉与经股动脉途径的比较
J Cardiovasc Dev Dis. 2024 Apr 3;11(4):115. doi: 10.3390/jcdd11040115.
7
How many endomyocardial biopsies are necessary in the first year after heart transplantation?心脏移植后的第一年需要进行多少次心内膜心肌活检?
Transpl Int. 1996;9(3):243-7. doi: 10.1007/BF00335393.
8
Global left ventricular relaxation: A novel tissue Doppler index of acute rejection in pediatric heart transplantation.整体左心室舒张功能:小儿心脏移植急性排斥反应的一种新型组织多普勒指标。
J Heart Lung Transplant. 2015 Sep;34(9):1190-7. doi: 10.1016/j.healun.2015.03.027. Epub 2015 Apr 11.
9
Cost-effectiveness of routine surveillance endomyocardial biopsy after 12 months post-heart transplantation.心脏移植术后12个月进行常规监测性心内膜心肌活检的成本效益
Circ Heart Fail. 2014 Sep;7(5):807-13. doi: 10.1161/CIRCHEARTFAILURE.114.001199. Epub 2014 Aug 7.
10
Endomyocardial Biopsy and Prevalence of Acute Cellular Rejection in Heart Transplantation.心肌内膜活检与心脏移植中急性细胞排斥的流行情况。
Transplant Proc. 2021 Jan-Feb;53(1):318-323. doi: 10.1016/j.transproceed.2020.08.014. Epub 2020 Oct 8.

引用本文的文献

1
Histopathological Characteristics of Percutaneous Endomyocardial Biopsy in Heart Transplant Rejection Surveillance: A Single Center Experience.心脏移植排斥反应监测中经皮心内膜心肌活检的组织病理学特征:单中心经验
Biomedicines. 2024 Oct 4;12(10):2258. doi: 10.3390/biomedicines12102258.
2
Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation.两种供体游离 DNA 检测方法与血液基因表达谱检测方法在心脏移植中的比较。
Clin Transplant. 2023 Jun;37(6):e14984. doi: 10.1111/ctr.14984. Epub 2023 Apr 10.

本文引用的文献

1
Comparison of Utilization Trends, Indications, and Complications of Endomyocardial Biopsy in Native Versus Donor Hearts (from the Nationwide Inpatient Sample 2002 to 2014).天然心脏与供体心脏心内膜心肌活检的使用趋势、适应症及并发症比较(来自2002年至2014年全国住院患者样本)
Am J Cardiol. 2018 Feb 1;121(3):356-363. doi: 10.1016/j.amjcard.2017.10.021. Epub 2017 Oct 31.
2
Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II.基因表达谱在心脏移植后排除急性排斥反应中的临床应用:CARGO II研究。
Eur Heart J. 2016 Sep 1;37(33):2591-601. doi: 10.1093/eurheartj/ehv682. Epub 2016 Jan 7.
3
Cost-effectiveness of routine surveillance endomyocardial biopsy after 12 months post-heart transplantation.心脏移植术后12个月进行常规监测性心内膜心肌活检的成本效益
Circ Heart Fail. 2014 Sep;7(5):807-13. doi: 10.1161/CIRCHEARTFAILURE.114.001199. Epub 2014 Aug 7.
4
Current status of endomyocardial biopsy.心肌活检的现状。
Mayo Clin Proc. 2011 Nov;86(11):1095-102. doi: 10.4065/mcp.2011.0296.
5
Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures.心脏移植患者心内膜心肌活检的并发症:对2117例连续手术的回顾性研究
Transplant Proc. 2011 Jun;43(5):1908-12. doi: 10.1016/j.transproceed.2011.03.010.
6
Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation.心脏移植术后早期和晚期中度心脏移植排斥反应(国际心脏移植学会2级)的自然病程
Circulation. 1996 Sep 15;94(6):1334-8. doi: 10.1161/01.cir.94.6.1334.
7
Endomyocardial biopsy.心内膜心肌活检
Ann Intern Med. 1982 Dec;97(6):885-94. doi: 10.7326/0003-4819-97-6-885.
8
Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center.成年心肌病患者经静脉右心室心内膜心肌活检的并发症:在一家三级转诊中心对546例连续诊断性操作进行的七年调查。
J Am Coll Cardiol. 1992 Jan;19(1):43-7. doi: 10.1016/0735-1097(92)90049-s.